↓ Skip to main content
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent
12 patents
guideline
2 clinical guideline sources

Readers on

mendeley
101 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
Published in
Journal of Clinical Oncology, July 2010
DOI 10.1200/jco.2009.26.9571
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Canada 2 2%
United States 1 <1%
Netherlands 1 <1%
United Kingdom 1 <1%
Brazil 1 <1%
Argentina 1 <1%
Unknown 94 93%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 15 15%
Researcher 12 12%
Other 11 11%
Student > Postgraduate 9 9%
Student > Master 7 7%
Other 13 13%
Unknown 34 34%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 39 39%
Agricultural and Biological Sciences 8 8%
Biochemistry, Genetics and Molecular Biology 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Business, Management and Accounting 2 2%
Other 6 6%
Unknown 39 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2026.
All research outputs
#2,665,770
of 29,400,575 outputs
Outputs from Journal of Clinical Oncology
#7,241
of 27,226 outputs
Outputs of similar age
#9,417
of 119,150 outputs
Outputs of similar age from Journal of Clinical Oncology
#53
of 178 outputs
Altmetric has tracked 29,400,575 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 27,226 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,150 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 178 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.